Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy.

Yu J, Christman KL, Chin E, Sievers RE, Saeed M, Lee RJ.

J Thorac Cardiovasc Surg. 2009 Jan;137(1):180-7. doi: 10.1016/j.jtcvs.2008.08.036.

2.

Stem-cell-based therapy and lessons from the heart.

Passier R, van Laake LW, Mummery CL.

Nature. 2008 May 15;453(7193):322-9. doi: 10.1038/nature07040. Review.

PMID:
18480813
3.

Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles.

Bouchentouf M, Benabdallah BF, Bigey P, Yau TM, Scherman D, Tremblay JP.

Gene Ther. 2008 Mar;15(6):404-14. Epub 2007 Dec 13.

PMID:
18079754
4.

Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells.

Heiss C, Wong ML, Block VI, Lao D, Real WM, Yeghiazarians Y, Lee RJ, Springer ML.

J Cell Physiol. 2008 May;215(2):366-73.

5.

Regulation of endothelial cell function by GRGDSP peptide grafted on interpenetrating polymers.

Patel S, Tsang J, Harbers GM, Healy KE, Li S.

J Biomed Mater Res A. 2007 Nov;83(2):423-33.

PMID:
17455217
6.

A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction.

Huang NF, Sievers RE, Park JS, Fang Q, Li S, Lee RJ.

Nat Protoc. 2006;1(3):1596-609.

PMID:
17406452
8.

Extracellular matrix and growth factors during heart growth.

Corda S, Samuel JL, Rappaport L.

Heart Fail Rev. 2000 Jun;5(2):119-30. Review.

PMID:
16228139
9.

Endotoxin: the uninvited guest.

Gorbet MB, Sefton MV.

Biomaterials. 2005 Dec;26(34):6811-7.

PMID:
16019062
10.

Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha.

Azarnoush K, Maurel A, Sebbah L, Carrion C, Bissery A, Mandet C, Pouly J, Bruneval P, Hagège AA, Menasché P.

J Thorac Cardiovasc Surg. 2005 Jul;130(1):173-9.

11.

Integrative signaling in angiogenesis.

Simons M.

Mol Cell Biochem. 2004 Sep;264(1-2):99-102. Review.

PMID:
15544039
12.

Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium.

Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ.

J Am Coll Cardiol. 2004 Aug 4;44(3):654-60.

13.

Alpha 3 beta 1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway.

Manohar A, Shome SG, Lamar J, Stirling L, Iyer V, Pumiglia K, DiPersio CM.

J Cell Sci. 2004 Aug 15;117(Pt 18):4043-54. Epub 2004 Jul 27.

14.
15.

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

Nisato RE, Tille JC, Jonczyk A, Goodman SL, Pepper MS.

Angiogenesis. 2003;6(2):105-19.

PMID:
14739617
16.
17.

The tissue engineeting puzzle: a molecular perspective.

Vogel V, Baneyx G.

Annu Rev Biomed Eng. 2003;5:441-63. Review.

PMID:
14527318
18.

An in vitro model of angiogenesis: basic features.

Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NF, Wheatley DN.

Angiogenesis. 1999;3(4):335-44.

PMID:
14517413
19.

Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle.

Springer ML, Ozawa CR, Banfi A, Kraft PE, Ip TK, Brazelton TR, Blau HM.

Mol Ther. 2003 Apr;7(4):441-9.

20.

Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect.

Nam JO, Kim JE, Jeong HW, Lee SJ, Lee BH, Choi JY, Park RW, Park JY, Kim IS.

J Biol Chem. 2003 Jul 11;278(28):25902-9. Epub 2003 Apr 17.

Supplemental Content

Support Center